Form 8-K





Washington, D.C. 20549







Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Earliest Event Reported: December 3, 2008



Intrepid Potash, Inc.

(Exact name of registrant as specified in its charter)




Delaware   001-34025   26-1501877

(State or other jurisdiction

of incorporation)

  (Commission file number)  

(IRS employer

identification no.)

700 17th Street, Suite 1700

Denver, Colorado 80202

(Address of principal executive offices, including zip code)

(303) 296-3006

(Registrant’s telephone number, including area code)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):


¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 210.14d-2(b))


¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Item 7.01 Regulation FD Disclosure.

On December 3, 2008, Robert P. Jornayvaz III, the Chairman of the Board and Chief Executive Officer of Intrepid Potash, Inc. (the “Company”), is scheduled to speak at the 19th Annual Citi Chemicals Conference. The presentation, which will begin at 3:15 p.m. Eastern Standard Time, will be webcast live and may be accessed via the Company’s website at by clicking on “Events and Presentations” on the Investor Relations page. A copy of the slides for Mr. Jornayvaz’s presentation at the conference is furnished as Exhibit 99.1 to this report.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.


Item 9.01 Financial Statements and Exhibits


  (d) Exhibits


Exhibit No.



99.1    Slides for presentation by Robert P. Jornayvaz III at the 19th Annual Citi Chemicals Conference on December 3, 2008.


Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: December 3, 2008   By:  

/s/    David W. Honeyfield

    David W. Honeyfield
    Executive Vice President, Chief Financial Officer, Treasurer and Secretary